Academia.eduAcademia.edu

Outline

Signal Detection - An Imperative Activity of Pharmacovigilance

2014

Abstract

Signal detection is important and core activity of pharmacovigilance. The primary aims of pharmacovigilance are to collect, monitor, assess and evaluate information regarding adverse effects, especially those which are serious or unexpected; and also involve providing information about potential and investible hazards. The signal detection and its dissemination seem to be important utility of pharmacovigilance database. It has power to prevent the epidemics of serious adverse drug reaction before gross damage to community. The historical medical calamities could have been prevented if technique like signal detection and pharmacovigilance would have been practiced since that time.

References (17)

  1. The Uppsala monitoring centre, WHO collaborating centre for drug monitoring. Viewpoints, watching for safe medicine part 1. Uppsala (Sweden), 2002.
  2. Safety of Medicines -A Guide to detecting and reporting adverse drug reactions. World Health Organization, 2002.
  3. World Health Organization. The importance of pharmacovigilance -safety monitoring of medicinal products. World Health Organization, Geneva, 2002.
  4. The Uppsala monitoring centre, WHO collaborating centre for drug monitoring. Viewpoints, watching for safe medicine, the scientific and technical story, part 2. Uppsala (Sweden), 2002.
  5. Couper M, Eds. The importance of pharmacovigilance. Safety monitoring of medicinal products. Geneva, WHO, 2002.
  6. Finney DJ. Systematic signalling of adverse reactions to drugs. Methods of Information in Medicine, 13(1), 1974, 1- 10.
  7. Amery W. Signal generation from spontaneous adverse event reports. Pharmacoepidemiology and Drug Safety, 8, 1999, 147-150.
  8. Meyboom R., Egberts A., Edwards I., Hekster Y., Koning F., Gribnau F., Principles of signal detection in Pharmacovigilance. Drug Safety, 16(6), 1997, 355-365.
  9. Bate A, Lindquist M, Edwards R, Orre R. A Data Mining Approach for Signal Detection and Analysis. Drug Safety, 25(6), 2002, 393-397.
  10. VanPuijenbroek E, Bate A, Leufkens H, Lindquist M, Orre R and Egberts A. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiology and drug safety, 11, 2002, 3-10.
  11. Härmark L & Van Grootheest A. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol 64, 2008, 743-752.
  12. Shibata A, Hauben M. Pharmacovigilance, Signal Detection and Signal Intelligence Overview. 14th International Conference on Information Fusion Chicago, Illinois, USA, July 5-8, 2011, 1515-1521.
  13. Freedman, L., Bayesian statistical methods. British medical journal, 313(7057), 1996, 569-70.
  14. Bate A. Bayesian Confidence Propagation Neural Network. Drug safety, 30(7), 2007, 623-625.
  15. CIOMS Working Group VIII. Practical aspects of signal detection in pharmacovigilance. Council for International Organizations of Medical Sciences (CIOMS), Geneva, 2010.
  16. Orre R, Lansner A, Bate A, Bayesian neural network with confidence estimation applied to data mining. Computational statistic data anal 34 (8), 2000, 473-93.
  17. Source of Support: Nil, Conflict of Interest: None.